Lv1
10 积分 2024-10-08 加入
In vitro metabolism of TAK-438, vonoprazan fumarate, a novel potassium-competitive acid blocker
2小时前
待确认
Mechanisms and Clinical Significance of Pharmacokinetic Drug Interactions Mediated by FDA and EMA-approved Hepatitis C Direct-Acting Antiviral Agents
27天前
已完结
Proton Pump Inhibitor Therapy Increases the Risk of Spontaneous Bacterial Peritonitis in Patients with HBV-Related Acute-on-Chronic Liver Failure
1个月前
已完结
Cannabidiol: Pharmacodynamics and pharmacokinetic in the context of neuropsychiatric disorders
1个月前
已关闭
The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations
1个月前
已完结
Vonoprazan-based versus proton pump inhibitor-based therapy inHelicobacter pylorieradication: an updated systematic review and meta-analysis of randomised trials
1个月前
已完结
The effects of drug-drug interaction on linezolid pharmacokinetics: A systematic review
1个月前
已完结
Linezolid pharmacokinetics: a systematic review for the best clinical practice
1个月前
已完结
Clinical pharmacokinetics of glipizide: a systematic review
1个月前
已完结
皖公网安备34019202002308
